Jasper Therapeutics, Inc.
Clinical trials sponsored by Jasper Therapeutics, Inc., explained in plain language.
-
New drug shows promise for Long-Term hive control
Disease control OngoingThis study looks at the long-term safety of a drug called briquilimab for people with chronic hives (urticaria). It includes 67 adults who have already been in a Jasper-sponsored trial. The goal is to see if the drug remains safe and effective over time, but it is not a cure.
Phase: PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New hope for chronic hives sufferers: experimental drug targets root cause
Disease control OngoingThis study tests an experimental drug called briquilimab in adults with chronic spontaneous urticaria (CSU) — long-lasting hives and itching that don't get better with usual antihistamines or omalizumab. The goal is to see if the drug is safe and can reduce symptoms by targeting …
Phase: PHASE1, PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC